Clinical Trial Update: Mycophenolate Mofetil in Systemic Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of mycophenolate mofetil for diffuse cutaneous systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Boston University | Conditions: Diffuse Cutaneous Systemic Sclerosis | Phase 1 | Status: COMPLETED